Related Experiment Video
Updated: Jan 16, 2026

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program
Published on: April 19, 2019
Association Between a Technology-Enabled Postpartum Program and Cardiovascular Disease Risk Reduction in Women With
Dan Yedu Quansah1, Natalie Martin1, Lisa McDonnell1
1Canadian Women Heart Health Centre, University of Ottawa Heart Institute, the Division of Cardiac Prevention and Rehabilitation, University of Ottawa Heart Institute, the Champlain Regional Stroke Network, the Ottawa Hospital, and the Faculty of Medicine, University of Ottawa, Ottawa, the Department of Obstetrics & Gynecology, Queen's University, Kingston, Ontario, and the Departments of Medicine, Obstetrics & Gynecology, and Community Health Sciences, University of Calgary, Calgary, Alberta, Canada; and the Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota.
Background:
To test the association between a behavior-change, risk-reduction intervention and cardiovascular disease (CVD) risk scores in women with previous hypertensive disorders of pregnancy (HDP).
Methods:
We completed a prospective, single-arm comparative pre-post study of women with recent HDP. The intervention was the CardioPrevent Postpartum Program, which involves health behavior-change coaches who counseled participants in 17 sessions over 12 months regarding behavioral changes (smoking, nutrition, physical activity), and worked with primary-care practitioners to optimize medical management of underlying risk factors (hypertension, dyslipidemia, diabetes mellitus). We measured changes in global risk scores (lifetime, Framingham Risk score) and clinical, psychosocial, and health behavior outcomes at 12 months compared with baseline.
Results:
Overall, 190 women were enrolled. Absolute reductions in Framingham and Lifetime Risk Scores at 12 months postintervention were 53.7% and 22.6%, respectively (both P≤.001). The intervention was associated with decreases in body weight (81.7±19.4 vs 74.1±19.8 kg, P<.001), waist circumference (96.9±15.5 vs 89.5±14.9 cm, P<.001), hypertension (50% vs 4.3%), and metabolic syndrome (53.6% vs 43.5%) between baseline and 12 months, but fasting plasma glucose and hemoglobin A1c were unchanged. Triglycerides, low-density lipoprotein cholesterol, and total cholesterol decreased; however, high-density lipoprotein cholesterol also decreased. We observed a 40.6% absolute reduction in postpartum depression, a 28.2% absolute reduction in anxiety, and a 67.9% absolute reduction in perceived stress at 12 months compared with baseline. Compared with baseline, the intervention was associated with a higher proportion of participants who met guideline recommendations for physical activity levels (48.4% vs 75.2%, P<.001), fruit and vegetable intake (21.5% vs 44.4%, P<.001), and medication adherence (29.4% vs 48.7%, P<.001) at 12 months.
Conclusion:
This behavior-change, risk-reduction intervention was associated with improvements in CVD risk factors at 12 months after initiation. Multidisciplinary health behavior-change programs may be effective CVD risk-reduction strategies for women with previous HDP.
Related Concept Videos
Peripheral Artery Disease III: Interprofessional Care
Coronary Artery Disease I: Introduction
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertension II: Pathophysiology
Hypertension V: Nursing Management
Cardiomyopathy VII: Pre and Post Operative Nursing Management

